|
Originally published In Press as doi:10.1074/jbc.M203240200 on October 17, 2002
J. Biol. Chem., Vol. 277, Issue 51, 49466-49472, December 20, 2002
Gangliosides Activate Trk Receptors by Inducing the Release
of Neurotrophins*
Stuart J.
Rabin,
Alessia
Bachis, and
Italo
Mocchetti
From the Department of Neuroscience, Georgetown University Medical
Center, Washington, D. C. 20057
We used NIH-3T3 fibroblasts expressing the
different Trk receptors to examine whether GM1 ganglioside and its
semisynthetic derivative LIGA20 activate various neurotrophin
receptors. GM1 induced autophosphorylation of TrkC more potently than
TrkA or TrkB receptors. In contrast, LIGA20 activated TrkB tyrosine
phosphorylation only. Therefore, Scatchard analysis was performed to
determine whether GM1 binds to TrkC. GM1 failed to displace
neurotrophin-3 binding, suggesting that this ganglioside does not act
as a ligand for Trk receptors. In addition, GM1 failed to induce
autophosphorylation of a chimeric receptor consisting of the
extracellular domain of the tumor necrosis factor receptor and the
intracellular domain of TrkA, suggesting that GM1 does not affect the
tyrosine kinase domain. We next determined whether GM1 induces the
release of neurotrophins from fibroblast cells. GM1 induced a rapid and
significant increase in the amount of neurotrophin-3, but not other
neurotrophins. This effect was independent of the presence of Trk
because K252a did not prevent GM1-mediated release of neurotrophin-3.
Moreover, GM1-mediated TrkC autophosphorylation was blocked by TrkC-IgG (but not TrkB-IgG) receptor bodies, further suggesting that GM1 activates TrkC by inducing the release of neurotrophin-3. This hypothesis was also tested in cultured cerebellar granule cells. GM1
induced neurotrophin-3 (but not brain-derived neurotrophic factor or
nerve growth factor) release. In contrast, LIGA20 increased the
secretion of brain-derived neurotrophic factor. Our data show that
gangliosides may activate different Trk receptors by differentially affecting the release of neurotrophins.
*
This work was supported by grants from the National Science
Foundation and the American Heart Association.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Neuroscience,
Georgetown University Medical Center, Research Bldg., Rm. EP04, P. O.
Box 571464, Washington, D. C. 20057. Tel.: 202-687-1197; Fax:
202-687-0617; E-mail: moccheti@georgetown.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. L. Dunbar, M. I. Sandstrom, J. Rossignol, and L. Lescaudron
Neurotrophic Enhancers as Therapy for Behavioral Deficits in Rodent Models of Huntington's Disease: Use of Gangliosides, Substituted Pyrimidines, and Mesenchymal Stem Cells.
Behav Cogn Neurosci Rev,
June 1, 2006;
5(2):
63 - 79.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Jou, J. H. Lee, S. Y. Park, H. J. Yoon, E.-H. Joe, and E. J. Park
Gangliosides Trigger Inflammatory Responses via TLR4 in Brain Glia
Am. J. Pathol.,
May 1, 2006;
168(5):
1619 - 1630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nishio, S. Fukumoto, K. Furukawa, A. Ichimura, H. Miyazaki, S. Kusunoki, T. Urano, and K. Furukawa
Overexpressed GM1 Suppresses Nerve Growth Factor (NGF) Signals by Modulating the Intracellular Localization of NGF Receptors and Membrane Fluidity in PC12 Cells
J. Biol. Chem.,
August 6, 2004;
279(32):
33368 - 33378.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|